G&S Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
G&S Capital's AMGN Position: Q2 2026 in Review
G&S Capital opened a new position in Amgen (AMGN) in Q2 2026: 4,359 shares worth $1.58M. The stake represents 0.46% of the portfolio and ranks #67 among its holdings. This is a return to the name: G&S Capital previously reported a position in AMGN as recently as Q2 2023.
G&S Capital first reported a position in AMGN in Q4 2017 and has held it in 3 quarters since. The position peaked at $3.06M in Q4 2017. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- G&S Capital held 4,359 shares of Amgen worth $1.58M as of Q2 2026.
- Amgen was a new G&S Capital position in Q2 2026.
- Amgen made up 0.46% of G&S Capital's portfolio in Q2 2026, its #67 holding.
- G&S Capital first reported a position in Amgen in Q4 2017 and has held it in 3 quarters since.
- G&S Capital's Amgen position peaked at $3.06M in Q4 2017.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.